VIVEX is expanding our Amnion & Wound Care Distribution Network. Interested in becoming a distribution partner? Click here to learn more.
NEWS
Vivex Announces New Peer-Reviewed Publication Demonstrating Long-Term Fusion Outcomes with VIA Form+™ in Lumbar Interbody Fusion
Read More
Vivex Biologics, Inc. Completes Subject Enrollment for its ASCEND Trial Evaluating VIA Disc NP™ for Symptomatic Disc Degeneration
Read More
VIVEX Biologics, Inc. Appoints Industry Veteran Jon E. Block, Ph.D., as Chief Clinical Officer
Read More
VIVEX Biologics, Inc. Executive Chair Nominated for Ernst & Young LLP Entrepreneur of the Year® 2025 Florida Award
Read More
VIVEX Biologics, Inc. Provides Enrollment Update for its ASCEND Study Examining Whether Supplementing Discs with VIA Disc NP™ Reduces Pain and/or Improves Function in Patients with Symptomatic Disc Degeneration
Read More
VIVEX Biologics, Inc. Provides Enrollment Update for its ASCEND Study Examining Whether Supplementing Discs with VIA Disc NP™ Reduces Pain and/or Improves Function in Patients with Symptomatic Disc Degeneration
Read More
VIVEX Biologics, Inc. Launches New CYGNUS® Dual Amniotic Allograft
Read More
VIVEX Biologics, Inc. Debuts Immersive Customer Experience Center
Read More
VIVEX Biologics, Inc. Launches CYGNUS® Matrix Disks
Read More
VIVEX Biologics, Inc. Launches VIA Mend™ Synthetic Bone Fillers
Read More